<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://trianabio.com/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://trianabio.com/triana-biomedicines-announces-the-appointment-of-rehan-verjee-as-chief-operating-officer/</loc><lastmod>2026-10-01T12:02:21+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-announces-vice-president-at-tr-411-at-aacr-annual-meeting-2026/</loc><lastmod>2026-10-19T09:12:14+00:00</lastmod></url><url><loc>https://trianabio.com/triana-bionotech-tr-411-journal-s-winter-first-presentation-for-alk-nsclc/</loc><lastmod>2026-10-01T12:02:58+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-announces-positive-preclinical-data-for-novel-molecular-glue-platform/</loc><lastmod>2026-10-01T12:03:04+00:00</lastmod></url><url><loc>https://trianabio.com/plus-and-minus-account-recipients-of-the-q1-2026-post-university-alliance-award/</loc><lastmod>2026-10-01T12:03:10+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-announces-oversubscribed-120m-series-b-financing/</loc><lastmod>2026-10-01T12:03:16+00:00</lastmod></url><url><loc>https://trianabio.com/appointment-of-caroline-santos-as-chief-medical-officer/</loc><lastmod>2026-10-01T12:03:31+00:00</lastmod></url><url><loc>https://trianabio.com/triana-and-pfizer-sign-research-collaboration-for-preclinical-molecular-glue-programs/</loc><lastmod>2026-10-01T12:03:37+00:00</lastmod></url><url><loc>https://trianabio.com/triana-to-present-at-ubs-biotechnology-private-company-symposium/</loc><lastmod>2026-10-01T12:03:45+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-announces-the-appointment-of-caroline-germa-as-chief-medical-officer-and-attracts-leading-drug-discovery-and-development-expert-to-its-scientific-advisory-board/</loc><lastmod>2026-09-30T15:37:09+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-and-pfizer-enter-into-a-research-collaboration-to-discover-novel-molecular-glue-degraders-for-multiple-disease-areas/</loc><lastmod>2026-09-30T15:24:22+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-to-present-at-ubs-biotechnology-private-company-virtual-symposium/</loc><lastmod>2026-09-30T15:25:37+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-announces-the-appointments-of-vito-palombella-as-chief-scientific-officer-and-reza-mazhari-as-chief-business-officer/</loc><lastmod>2026-09-30T15:36:41+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-named-most-promising-new-company-in-biospaces-nextgen-2023-list/</loc><lastmod>2026-09-30T15:33:21+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-announces-participation-in-upcoming-investor-conference/</loc><lastmod>2026-09-30T15:32:25+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-attracts-leading-protein-science-and-clinical-oncology-experts-to-its-scientific-advisory-board/</loc><lastmod>2026-09-30T15:34:30+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-launches-with-110m-to-unlock-the-full-potential-of-molecular-glues/</loc><lastmod>2026-10-01T12:04:34+00:00</lastmod></url><url><loc>https://trianabio.com/triana-biomedicines-announces-participation-in-goldman-sachs-healthcare-private-company-conference/</loc><lastmod>2026-10-19T10:41:53+00:00</lastmod></url></urlset>
